BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14696114)

  • 1. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice.
    Miki T; Yano S; Hanibuchi M; Kanematsu T; Muguruma H; Sone S
    Int J Cancer; 2004 Feb; 108(4):511-5. PubMed ID: 14696114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice.
    Miki T; Yano S; Hanibuchi M; Sone S
    Oncol Res; 2000; 12(5):209-17. PubMed ID: 11417746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice.
    Zhang H; Yano S; Miki T; Goto H; Kanematsu T; Muguruma H; Uehara H; Sone S
    Clin Exp Metastasis; 2003; 20(2):153-9. PubMed ID: 12705636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with a new bisphosphonate, minodronate (YM529), and chemotherapy for multiple organ metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Yano S; Zhang H; Hanibuchi M; Miki T; Goto H; Uehara H; Sone S
    Clin Cancer Res; 2003 Nov; 9(14):5380-5. PubMed ID: 14614023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
    Muguruma H; Yano S; Kakiuchi S; Uehara H; Kawatani M; Osada H; Sone S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8822-8. PubMed ID: 16361571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice.
    Yamada T; Muguruma H; Yano S; Ikuta K; Ogino H; Kakiuchi S; Hanibuchi M; Uehara H; Nishioka Y; Sone S
    Mol Cancer Ther; 2009 Jan; 8(1):119-26. PubMed ID: 19139120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice.
    Sone S; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Miki T; Nishioka Y; Shinohara T
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S26-31. PubMed ID: 10357555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice.
    Sakaguchi S; Goto H; Hanibuchi M; Otsuka S; Ogino H; Kakiuchi S; Uehara H; Yano S; Nishioka Y; Sone S
    Clin Exp Metastasis; 2010 May; 27(5):351-9. PubMed ID: 20464627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage colony-stimulating factor gene transduction into human lung cancer cells differentially regulates metastasis formations in various organ microenvironments of natural killer cell-depleted SCID mice.
    Yano S; Nishioka Y; Nokihara H; Sone S
    Cancer Res; 1997 Feb; 57(4):784-90. PubMed ID: 9044861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.
    Iguchi H; Tanaka S; Ozawa Y; Kashiwakuma T; Kimura T; Hiraga T; Ozawa H; Kono A
    Cancer Res; 1996 Sep; 56(17):4040-3. PubMed ID: 8752176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
    Nokihara H; Yano S; Nishioka Y; Hanibuchi M; Higasida T; Tsuruo T; Sone S
    Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
    Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
    J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice.
    Ogino H; Yano S; Kakiuchi S; Muguruma H; Ikuta K; Hanibuchi M; Uehara H; Tsuchida K; Sugino H; Sone S
    Clin Cancer Res; 2008 Feb; 14(3):660-7. PubMed ID: 18245525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
    Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice.
    Yano S; Muguruma H; Matsumori Y; Goto H; Nakataki E; Edakuni N; Tomimoto H; Kakiuchi S; Yamamoto A; Uehara H; Ryan A; Sone S
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8789-98. PubMed ID: 16361567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel metastasis model of human lung cancer in SCID mice depleted of NK cells.
    Yano S; Nishioka Y; Izumi K; Tsuruo T; Tanaka T; Miyasaka M; Sone S
    Int J Cancer; 1996 Jul; 67(2):211-7. PubMed ID: 8760590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice.
    Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Kawano T; Sone S
    Int J Cancer; 1998 Nov; 78(4):480-5. PubMed ID: 9797137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bone metastasis model with osteolytic and osteoblastic properties of human lung cancer ACC-LC-319/bone2 in natural killer cell-depleted severe combined immunodeficient mice.
    Otsuka S; Hanibuchi M; Ikuta K; Yano S; Goto H; Ogino H; Yamada T; Kakiuchi S; Nishioka Y; Takahashi T; Sone S
    Oncol Res; 2009; 17(11-12):581-91. PubMed ID: 19806789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
    J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.